Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
IGM Biosciences is a biotechnology company that develops medicine for people with infectious infections, autoimmune diseases, and cancer.
Elevation Oncology is a clinical-stage biopharmaceutical company focused on the development of precision medicines for patients.
Chroma Medicine is a biotechnology company that develops genetic medicines for the treatment of genetic disorders.
2seventy bio is an immuno-oncology cell therapy company that discovers and develops cancer therapies.
Via is a transport company that offers public mobility solutions for transit agencies, school districts, cities, and corporations.
Synthekine is a development stage biotherapeutics company focused on the engineering of novel specific and potent cytokine therapies.
Thrive Earlier Detection is a healthcare company that integrates earlier cancer detection into routine medical care.
Dice Therapeutics is a clinical-stage biopharmaceutical company that makes medicines for chronic autoimmune and inflammatory diseases.
Loadsmart is the end-to-end AI freight platform for shippers with embedded operational services.
Bigfoot Biomedical is a medical device company changing diabetes care for people with insulin-requiring diabetes.
Chinook Therapeutics is a biotechnology company that specializes in the fields of therapeutics and life science.
IntelyCare is revolutionizing healthcare staffing, scheduling, and training by offering an enterprise workforce management platform.
Magnolia Medical Technologies is a device development company that focuses on improving the accuracy of diagnostic blood culture tests.
Quell Therapeutics is a cell therapy company
Shoreline Biosciences is a biomedical company intended to establish immunotherapies for seriously ill patients.
Cedilla Therapeutics is a biotechnology company that develops targeted small molecules for the treatment of cancer and other diseases.
Equillium is a biotechnology company that develops products for autoimmune and inflammatory disorders with an unmet medical need.
Longeveron is a biotechnology company that focuses on developing cellular therapies for chronic aging-related and life-threatening diseases.
Solid Biosciences is a life science company that conducts research for the treatment of Duchenne muscular dystrophy.
Bicara Therapeutics develops dual-action cancer therapies, combining targeted treatments with tumor modulators for enhanced impact.
Immunic is a biopharmaceutical company that develops a pipeline of selective oral immunology therapies.
Third Arc Bio is a biotech company developing multifunctional antibodies for inflammatory and immunology diseases.
CesiumAstro provides out-of-the-box communication systems for satellites, UAVs, launch vehicles, and other space or airborne platforms.
Vaxcyte focuses on developing vaccines designed to prevent or treat some of the most common and deadly infectious diseases worldwide.
Janus Henderson Investors has invested in 229 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Janus Henderson Investors's top investment sectors include Biotechnology, Health Care, Medical, Therapeutics, Life Science. The firm invests across 33 different industry categories.
Among tracked funding rounds, Vaxcyte received $632.5M in a Post Ipo Equity round. Janus Henderson Investors's total known invested capital is $34.7B.
Janus Henderson Investors's average investment size is $151.4M across its portfolio of 229 companies.
Recent Janus Henderson Investors portfolio additions include IGM Biosciences, Elevation Oncology, Chroma Medicine, 2seventy bio, Via. These companies were founded in 2020 or later.